FDA Approved: ARAZLO — Original Application (Bausch Health US, LLC)

View source ↗

Summary

The FDA approved ARAZLO, a tazarotene topical lotion, under an original application by Bausch Health US, LLC for the treatment of plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ARAZLO (TAZAROTENE)

Snippet

ORIG AP for ARAZLO (TAZAROTENE)